State of the art treatment of hepatitis B virus hepatocellular carcinoma and the role of hepatitis B surface antigen post‐liver transplantation and resection

Chronic hepatitis B virus (HBV) infection is the major aetiology of hepatocellular carcinoma (HCC). The optimal goal of therapy, hepatitis B surface antigen (HBsAg) loss and anti‐HBs production, is achieved rarely and HBsAg‐associated HCC risk is well recognized. Here we review the role of HBsAg in...

Descripción completa

Detalles Bibliográficos
Autores principales: Schemmer, Peter, Burra, Patrizia, Hu, Rey‐Heng, Hüber, Christian M., Loinaz, Carmelo, Machida, Keigo, Vogel, Arndt, Samuel, Didier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Reviews & Meta‐analyses
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300017/
https://www.ncbi.nlm.nih.gov/pubmed/34846790
http://dx.doi.org/10.1111/liv.15124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300017/
https://www.ncbi.nlm.nih.gov/pubmed/34846790
http://dx.doi.org/10.1111/liv.15124

Ejemplares similares